Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study

Heissigerova, Jarmila; Callanan, David; de Smet, Marc; Srivastava, Sunil; Karkanova, Michala; Garcia-Garcia, Olga; KADAYIFÇILAR, SİBEL; Ozyazgan, Yılmaz; Vitti, Robert; Erickson, Kristine; Athanikar, Aditya; Chu, Karen; Saroj, Namrata; Sundaram, Preethi; Varona, Rafael; Corp-dit-Genti, Valerie; Buggage, Ronald; Cheng, Yenchieh; Soo, Yuhwen; Nguyen, Quan

doi:10.1016/j.ophtha.2018.09.044

Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study

Copy For Citation

Heissigerova J., Callanan D., de Smet M. D., Srivastava S. K., Karkanova M., Garcia-Garcia O., ...More

OPHTHALMOLOGY, vol.126, no.3, pp.428-437, 2019 (SCI-Expanded)

Publication Type: Article / Article
Volume: 126 Issue: 3
Publication Date: 2019
Doi Number: 10.1016/j.ophtha.2018.09.044
Journal Name: OPHTHALMOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.428-437
Istanbul University Affiliated: No

Abstract

Purpose: To assess efficacy and safety of sarilumab, a human anti-interleukin-6 receptor antibody, for treatment of posterior segment noninfectious uveitis (NIU).